SCHEMBL7474738

SCHEMBL7474738

CCCCCN(NC(=S)NC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
GAA P10253 3/20 0.50
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
EPHX1 P07099 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NAAA Q02083 1/20 0.47
MITF O75030 1/20 0.46
ALOX12 P18054 1/20 0.46
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
ACHE P22303 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475776 0.96 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2GAALMNAHTT
SCHEMBL5447985 0.78 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2GAALMNAHTT
SCHEMBL11581830 0.76 SMN1; SMN2 (0.72) ALDH1A1SMN1; SMN2GAANAAAMITF
SCHEMBL16587380 0.75 NAAA (0.72) ALDH1A1SMN1; SMN2GAAHTTL3MBTL1
SCHEMBL21894756 0.75 NAAA (0.72) ALDH1A1SMN1; SMN2GAAHTTL3MBTL1
SCHEMBL16587391 0.75 NAAA (0.72) ALDH1A1SMN1; SMN2GAAHTTL3MBTL1
SCHEMBL16587395 0.75 NAAA (0.72) ALDH1A1SMN1; SMN2GAAHTTL3MBTL1
SCHEMBL28425954 0.75 NAAA (0.55) ALDH1A1GAAL3MBTL1NAAAPOLB
SCHEMBL7063202 0.75 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2GAALMNAHTT
SCHEMBL22506569 0.72 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GAALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183245-A4 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2002-10-02 EP disclosed
EP-1194421-A4 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2002-09-11 EP disclosed
EP-1194421-A1 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2002-04-10 EP disclosed
EP-1183245-A1 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2002-03-06 EP disclosed
WO-2001002379-A1 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2001-01-11 WO disclosed
WO-2000064880-A1 SELECTIVE NPY (Y5) ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-11-02 WO disclosed